Power supply provided with Afinion 2
Recall Z-2192-2020, part of FDA recall event 85313. See Abbott Diagnostics Technologies AS's company page.
Abbott Diagnostics Technologies AS started this Class II device recall on Mar 23, 2020 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Mar 23, 2020
- Status: Ongoing
The analyzer system may have an electrostatic discharge and sparking of the power supply provided with the analyzers resulting in the power supply becoming non-functional.
- Product
- Power supply provided with Afinion 2, Catalog numbers 1116553, 1116554, 1116556, 1116557, 1116597, 1116598, 1116663, 1116679, 1116680, 1116681, 1116682, 1116684, 1116770, 1116771, 1116772, 1116777, 1116778, 1116970, 1116971, 1116985, 1116986, IVD. The firm name on the label is Abbott Diagnostics Technologies AS, Oslo, Norway. Power supply provided with Alere Afinion AS100 Analyzer, Catalog numbers 1115175, 1115390, 1116049, 1116050, 1116053, 1116054, 1116456, and 1116980. The firm name on the label is Alere Technologies AS, Oslo, Norway.
- Quantity
- 42,237 instruments
- Lots and codes
- All serial numbers are affected.
- Distribution
- Distribution was made to NJ. There was no direct government/military distribution. Foreign distribution was made to Canada, Argentina, Australia, Bangladesh, Brazil, Cambodia, Chile, China, Colombia, Denmark, Finland, France, Georgia, Germany, Guatemala, Hong Kong, Iceland, India, Italy, Ivory Coast, Japan, Korea, Madagascar, Malaysia, Mexico, Mongolia, Myanmar, The Netherlands, Norway, Oman, Pakistan, Peru, Philippines, Poland, Saudi Arabia, Singapore, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Tanzania, Thailand, Timur, Trinidad & Tobago, United Kingdom, and Zimbabwe.
- Recalling firm
- Abbott Diagnostics Technologies AS, Oslo, N/A, Norway
- How the firm notified
- Letter
- FDA classified
- May 29, 2020
Newest first, one product per recall event; search them all
- Afinion 2 Analyzer, model #1116986, US refurbished, CLIA waived.Z-2736-2024 · Class II · Jun 17, 2024 · Ongoing
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports